In this issue:
Clinical features and outcomes of PMF
Momelotinib for myelofibrosis
Postinduction MRD predicts SCT outcomes in NPM1-mutated AML
Inferior PFS after SCT for double-expressor and double-hit lymphomas
Ofatumumab + mini-CHOP in elderly DLBCL
Health-related QOL in indolent NHL treated with bendamustine ±obinutuzumab
Ofatumumab for Waldenström’s macroglobulinaemia
Comorbidities, not age, predict survival post-HCT in older HL
High-dose therapy and autologous SCT for POEMS syndrome
Please login below to download this issue (PDF)